Premium
Mixed lichenoid and psoriasiform drug eruption induced by rifampicin
Author(s) -
Feng Xia,
Ye Xin,
Xu Jixiang,
Li Changqiang
Publication year - 2020
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13222
Subject(s) - medicine , rifampicin , drug eruption , dermatology , drug , drug reaction , tuberculosis , first line , ethambutol , pharmacology , pathology
Rifampicin is an essential first line anti‐tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of mixed lichenoid and psoriasiform drug eruption induced by rifampicin.